Abstract
A novel series of uracil derivatives with a 3,5-dimethylbenzyl group at the C-6 position were synthesized and evaluated as non-nucleoside HIV-1 reverse transcriptase inhibitors. Purity of the compounds has been confirmed by TLC. Structures of these compounds were established on the basis of elemental analyses and spectral studies. Some of the tested compounds showed moderate to potent activities against wildtype HIV-1, and N-1 alkylated derivatives were highly active.
Similar content being viewed by others
References
Gallo, R.C., Salahuddin, S.Z., Popovic, M., Shearer, G.M., Kaplan, M., Haynes, B.F., Palker, T.J., Redfield, R., Oleske, J., Safai, B., White, G., Foster, P., and Markham, P.D., Science, 1984, vol. 224, p. 500.
Tronchet, J.M. and Seman, M., Curr. Top. Med. Chem., 2003, vol. 13, p. 1496.
Tarby, C., Curr. Top. Med. Chem., 2005, vol. 4, p. 1045.
Sluis-Cremer, N., Alpay Temiz, N., and Bahar, I., Curr. HIV Res., 2004, vol. 2, p. 323.
De Clercq, E., Nat. Rev. Drug Disc., 2002, vol. 1, p. 13.
De Clercq, E., J. Med. Chem., 2005, vol. 48, p. 1297.
De Clercq, E., Nat. Rev. Drug Disc., 2007, vol. 6, p. 1001.
Baba, M., Tanaka, H., De Clercq, E., Pauwels, R., Balzarini, J., Schols, D., Nakashima, H., Perno, C.F., Walker, R.T., and Miyasaka, T., Biochem. Biophys. Res. Commun., 1989, vol. 165, p. 1375.
Miyasaka, T., Tanaka, T., Baba, M., Hayakawa, H., Walker, R.T., Balzarini, J., and De Clercq, E.J., Med. Chem., 1989, vol. 32, p. 2507.
Uckun, F.M.J., Enzyme Inhib. Med. Chem., 2006, vol. 21, p. 329.
Artico, M., Drugs Future, 2002, vol. 27, p. 159.
Marongiu, M.E., Pani, A., Musiu, C., La Colla, P., Mai, A., Sbardella, G., Massa, S., and Artico, M., Recent Res. Dev. Med. Chem., 2001, vol. 1, p. 65.
De Clercq, E., Int. J. Antimicrob. Agents, 2009, vol. 33, p. 307.
Mao, C., Sudeck, E.A., Venkatachalam, T.K., and Uckun, F.M., Biochem. Pharmacol., 2000, vol. 6, p. 1251.
Nawrozkij, M.B., Rotili, D., Tarantino, D., Botta, G., Eremiychuk, A.S., Musmuca, I., Ragno, R., Samuele, A., Zanoli, S., Armand, U.M., Clotet-Codina, I., Novakov, I.A., Orlinson, B.S., Maga, G., Est, J.A., and Artico, M.J., Med. Chem., 2008, vol. 51, p. 4641.
Mai, A., Artico, M., Sbardella, G., Massa, S., Novellino, E., Greco, G., Loi, A.G., Tremontano, E., Marongiu, M.E., and Colla, P.L.J., Med. Chem., 1999, vol. 42, p. 619.
Petersen, L., Hansen, T.H., Khalifa, N.M., Pedersen, E.B., and Nielsen, C., Synthesis of new MKC-442 analogus containing alkenyl chains or reactive functionalities, in Monatshefte für Chemie, 2002, vol. 133, p. 1031.
Nielsen, C.M., Bygbjerg, I.C., and Vestergaard, B.F., Lancet, 1987, vol. 1, p. 566.
Mosmann, T., J. Immunol. Methods, 1983, vol. 65, p. 55.
Author information
Authors and Affiliations
Corresponding author
Additional information
The article is published in the original.
Rights and permissions
About this article
Cite this article
Khalifa, N.M., Pedersen, E.B., Nielsen, C. et al. Synthesis and evaluation of novel 6-(3,5-dimethylbenzyl)uracil analogs as potential anti-HIV-1 agents. Russ J Bioorg Chem 40, 579–585 (2014). https://doi.org/10.1134/S1068162014040050
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1068162014040050